MAPT and Alzheimer disease: From these data, we are able to extract the rate of tau seed replication in human AD and find that this rate is orders of magnitude slower than that measured for purified tau in vitro, quantifying the effectiveness of innate cellular mechanisms that curtail tau seed replication.